This company is involved in the pharmaceutical sector, with a portfolio of FDA-approved drugs but currently has no active involvement in rare diseases or orphan drug designations.
0
Orphan Designations
24
FDA Approvals
Latest: ADVIL DUAL ACTION WITH ACETAMINOPHEN (2020)
0
Active Trials
0
Rare Diseases
0
News (30d)
Quiet
Haleon US Holdings LLC is a company with 0 orphan drug designations across 0 rare diseases, including 24 FDA-approved therapies.
Disease-by-disease pipeline progression from orphan designation through clinical trials to FDA approval.
Source: FDA Orphan Drug Designations, ClinicalTrials.gov, Drugs@FDA
No pipeline data available yet.